This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

CooperSurgical Launches The New MityOne® Vacuum-Assisted Delivery System

Stocks in this article: COO

TRUMBULL, Conn., Feb. 28, 2013 /PRNewswire/ --  CooperSurgical, makers of the trusted Mityvac®, announced today the release of the new MityOne Vacuum-Assisted Delivery System for vaginal and C-section deliveries. This one-piece VAD device is available with a choice of bell and mushroom-style cups that are among the gentlest and most effective in the industry.

(Photo: )(Logo: )

"The MityOne Vacuum-Assisted Delivery System was designed based on feedback from prominent obstetricians who wanted greater control during deliveries. The new shorter stem, self-limiting vacuum and gentle cup interfaces ensure the device is safe, effective and easy to use," said Dr. Robert Auerbach, Executive Vice-President and Chief Medical Officer for CooperSurgical.

The MityOne vacuum pump will not exceed recommended suction levels of 58 cmHg, providing precise control and safe pressure throughout the delivery procedure. With the release trigger positioned closer to the operator, it is simple to reach and disengage as needed. The pump creates vacuum with minimal effort, and no assistant is required.

MityOne works in conjunction with the MitySoft® Bell Cup and M-Style® Mushroom® Cup, both highly effective yet gentle designs. The M-Style Mushroom Cup has a proven success rate of up to 97% with laceration rates averaging less than 1.59%. The semi rigid MitySoft Bell Cup reduces the risk of pop-offs while providing the pulling power of a mushroom cup. Both cups have an integrated filter that allows for 360-degree air movement to secure traction levels.

The Mityvac family of products, including the new MityOne, has ensured safer vacuum-assisted deliveries for over 20 years.

About CooperSurgicalSince our founding in 1990, CooperSurgical has researched, developed and manufactured a wide range of trusted brands that have advanced the standard of women's health care. Our products are used by physicians and health care professionals in hospitals and their practices for a wide variety of procedures from basic annual gynecological exams to complex surgeries.

CooperSurgical, Inc., is a wholly owned subsidiary of The Cooper Companies (NYSE:COO). Headquartered in Trumbull, CT, the company produces and markets a wide array of products for use by women's health care clinicians. More information can be found at

About The Cooper Companies

The Cooper Companies, Inc. ("Cooper") is a global medical device company publicly traded on the NYSE Euronext (NYSE:COO).  Cooper is dedicated to being A Quality of Life Company™ with a focus on delivering shareholder value.  Cooper operates through two business units, CooperVision and CooperSurgical.  CooperVision brings a refreshing perspective on vision care with a commitment to crafting a wide range of high-quality products for contact lens wearers and providing focused practitioner support.  CooperSurgical focuses on supplying women's health clinicians with market leading products and treatment options to improve the delivery of healthcare to women.  Headquartered in Pleasanton, CA, Cooper has approximately 7,800 employees with products sold in over 100 countries.  For more information, please visit

SOURCE CooperSurgical

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,778.15 +421.28 2.43%
S&P 500 2,061.23 +48.34 2.40%
NASDAQ 4,748.3960 +104.0840 2.24%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs